- A group of 21 Republican AGs sent a letter to the U.S. Drug Enforcement Administration requesting emergency action to schedule bromazolam under the Controlled Substances Act.
- The letter describes bromazolam—an unregulated benzodiazepine that is often referred to as “designer Xanax”—as “highly potent and unpredictable” and “particularly lethal for unsuspecting users” because of its unregulated status, and further cites to the drug’s use having been linked to rising drug overdose deaths.
- The AGs urge the DEA to initiate emergency or permanent scheduling of bromazolam, to equip prosecutors with tools to hold traffickers accountable, and send a signal that the drug poses a serious risk to public health.